Amivantamab-Associated Vasculitis in a Patient with EGFR Exon 20 Insertion Non-Small Cell Lung Cancer: A Case Report
Non-Small Cell Lung Cancer, Immune Checkpoint Inhibitor, Amivantamab, Vasculitis